Vishal N Rao1, Mary Jo Obeid2, Francesca Rigiroli3, Stuart D Russell2, Chetan B Patel2, Jeroen Molinger2, Rajan T Gupta4, Richa Agarwal2, Marat Fudim5. 1. Division of Cardiology, Duke University Medical Center, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina. Electronic address: vishal.rao@duke.edu. 2. Division of Cardiology, Duke University Medical Center, Durham, North Carolina. 3. Department of Radiology, Duke University Medical Center, Durham, North Carolina. 4. Department of Radiology, Duke University Medical Center, Durham, North Carolina; Department of Surgery, Duke University Medical Center, Durham, North Carolina; Duke Cancer Institute Center for Prostate and Urologic Cancers, Durham, North Carolina. 5. Division of Cardiology, Duke University Medical Center, Durham, North Carolina; Duke Clinical Research Institute, Durham, North Carolina.
Abstract
BACKGROUND: Pericardial adipose tissue (PAT) is associated with adverse cardiovascular outcomes in those with and without established heart failure (HF). However, it is not known whether PAT is associated with adverse outcomes in patients with end-stage HF undergoing left ventricular assist device (LVAD) implantation. This study aimed to evaluate the associations between PAT and LVAD-associated outcomes. METHODS AND RESULTS: We retrospectively measured computed tomography-derived PAT volumes in 77 consecutive adults who had available chest CT imaging prior to HeartMate 3 LVAD surgery between October 2015 and March 2019 at Duke University Hospital. Study groups were divided into above-median (≥219 cm3) and below-median (<219 cm3) PAT volume. Those with above-median PAT had a higher proportion of atrial fibrillation, chronic kidney disease and ischemic cardiomyopathy. Groups with above-median vs below-median PAT had similar Kaplan-Meier incidence rates over 2 years for (1) composite all-cause mortality, redo-LVAD surgery and cardiac transplantation (35.9 vs 32.2%; log-rank P = 0.65) and (2) composite incident hospitalizations for HF, gastrointestinal bleeding, LVAD-related infection, and stroke (61.5 vs 60.5%; log-rank P = 0.67). CONCLUSIONS: In patients with end-stage HF undergoing LVAD therapy, PAT is not associated with worse 2-year LVAD-related outcomes. The significance of regional adiposity vs obesity in LVAD patients warrants further investigation.
BACKGROUND: Pericardial adipose tissue (PAT) is associated with adverse cardiovascular outcomes in those with and without established heart failure (HF). However, it is not known whether PAT is associated with adverse outcomes in patients with end-stage HF undergoing left ventricular assist device (LVAD) implantation. This study aimed to evaluate the associations between PAT and LVAD-associated outcomes. METHODS AND RESULTS: We retrospectively measured computed tomography-derived PAT volumes in 77 consecutive adults who had available chest CT imaging prior to HeartMate 3 LVAD surgery between October 2015 and March 2019 at Duke University Hospital. Study groups were divided into above-median (≥219 cm3) and below-median (<219 cm3) PAT volume. Those with above-median PAT had a higher proportion of atrial fibrillation, chronic kidney disease and ischemic cardiomyopathy. Groups with above-median vs below-median PAT had similar Kaplan-Meier incidence rates over 2 years for (1) composite all-cause mortality, redo-LVAD surgery and cardiac transplantation (35.9 vs 32.2%; log-rank P = 0.65) and (2) composite incident hospitalizations for HF, gastrointestinal bleeding, LVAD-related infection, and stroke (61.5 vs 60.5%; log-rank P = 0.67). CONCLUSIONS: In patients with end-stage HF undergoing LVAD therapy, PAT is not associated with worse 2-year LVAD-related outcomes. The significance of regional adiposity vs obesity in LVAD patients warrants further investigation.
Authors: Muhammad Shahzeb Khan; Melana Yuzefpolskaya; Muhammad Mustafa Memon; Muhammad Shariq Usman; Naser Yamani; A Reshad Garan; Ryan T Demmer; Paolo C Colombo Journal: ASAIO J Date: 2020-04 Impact factor: 2.872
Authors: Kevin J Clerkin; Yoshifumi Naka; Donna M Mancini; Paolo C Colombo; Veli K Topkara Journal: JACC Heart Fail Date: 2016-09-07 Impact factor: 12.035
Authors: Amir A Mahabadi; Joseph M Massaro; Guido A Rosito; Daniel Levy; Joanne M Murabito; Philip A Wolf; Christopher J O'Donnell; Caroline S Fox; Udo Hoffmann Journal: Eur Heart J Date: 2009-01-09 Impact factor: 29.983
Authors: Brian A Houston; Rohan J Kalathiya; Steven Hsu; Rahul Loungani; Mary E Davis; Samuel T Coffin; Nicholas Haglund; Simon Maltais; Mary E Keebler; Peter J Leary; Daniel P Judge; Gerin R Stevens; John Rickard; Chris M Sciortino; Glenn J Whitman; Ashish S Shah; Stuart D Russell; Ryan J Tedford Journal: J Heart Lung Transplant Date: 2016-02-09 Impact factor: 10.247